GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	225.46	75.47	829.34	585.85	73.57	22.16
Cash & Short-Term Investments	225.46	75.47	829.34	585.85	73.57	22.16
Cash Growth	-60.22%	-90.90%	41.56%	696.36%	232.01%	-91.18%
Accounts Receivable	431.33	619.73	685.96	424.68	253.94	269.39
Other Receivables	31.84	50.34	23.89	318.64	408.81	221.5
Receivables	1,777	1,661	1,176	1,165	830.42	641.44
Inventory	1,520	945.21	695.27	485.89	500.45	456.05
Prepaid Expenses	-	-	-	-	17.58	20.46
Other Current Assets	312.32	183.55	164.7	216.65	126.47	143.34
Total Current Assets	3,835	2,865	2,866	2,454	1,548	1,283
Property, Plant & Equipment	634.64	641.17	572.14	548.11	540.21	476.53
Long-Term Investments	24.17	7.34	6.34	24.45	12.3	21.51
Goodwill	-	-	-	137.65	238.65	238.65
Long-Term Deferred Tax Assets	-	23.33	17.43	-	-	-
Other Long-Term Assets	119.5	115.83	96.48	21.33	85.09	97.2
Total Assets	4,614	3,653	3,558	3,185	2,425	2,117
Accounts Payable	1,339	486.93	524.53	176.8	104.54	49.28
Accrued Expenses	550.62	577.83	524.12	304.51	581.22	522.35
Short-Term Debt	-	-	-	-	118.21	145.73
Current Portion of Leases	-	38.28	28.39	17.48	29.52	-
Current Income Taxes Payable	196.66	159.39	97.93	308.57	17.38	1.23
Other Current Liabilities	325.69	313.45	348.98	585.89	161.22	170.56
Total Current Liabilities	2,412	1,576	1,524	1,393	1,012	889.15
Long-Term Leases	80.84	81.2	68.63	52.07	32.24	-
Long-Term Deferred Tax Liabilities	11.44	-	-	11.31	22.46	15.09
Total Liabilities	2,505	1,657	1,593	1,457	1,067	904.25
Common Stock	835.14	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,273	1,160	1,130	892.71	522.24	377.36
Total Common Equity	2,108	1,995	1,965	1,728	1,357	1,213
Minority Interest	0.6	0.6	0.6	0.58	0.58	0.59
Shareholders' Equity	2,109	1,996	1,965	1,728	1,358	1,213
Total Liabilities & Equity	4,614	3,653	3,558	3,185	2,425	2,117
Total Debt	80.84	119.48	97.03	69.55	179.97	145.73
Net Cash (Debt)	144.61	-44.01	732.32	516.3	-106.41	-123.58
Net Cash Growth	-65.11%	-	41.84%	-	-	-
Net Cash Per Share	1.73	-0.53	8.77	6.18	-1.27	-1.48
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Working Capital	1,423	1,289	1,342	1,060	536.41	394.3
Book Value Per Share	25.25	23.89	23.53	20.69	16.25	14.52
Tangible Book Value	2,108	1,995	1,965	1,590	1,119	973.85
Tangible Book Value Per Share	25.25	23.89	23.53	19.04	13.40	11.66
Land	17.59	17.59	17.59	12.65	12.65	12.65
Buildings	74.34	74.34	83.47	97.81	97.81	97.81
Machinery	709.92	696.44	668.83	662.18	629.59	571.91
Construction In Progress	146.44	152.54	108.51	88.86	98.67	122.98
Leasehold Improvements	24.27	24.27	26.81	26.85	42.34	42.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.